February 21, 2017: While BMS has become the subject of takeover rumors as share prices have declined about 15 percent since January, company leadership has not sat idle.
February 21, 2017: Pharma and biotech industry insiders are waiting with bated breath to see who President Donald Trump appoints as the new commissioner of the FDA.
February 21, 2017: Pfizer is continuing its construction projects in Rocky Mount, NC. Hospira, acquired by Pfizer in 2015, had announced the expansion of its new facility the same year.
February 21, 2017: According to STAT, Stephen Kelsey, director of Moderna’s oncology division, is leaving for a California startup. Kelsey joined Moderna as president of Onkaido Therapeutics in July 2014, Moderna’s oncology drug development company.